Rapt Therapeutics logo

Rapt Therapeutics Share Price (NASDAQ: RAPT)

$11.4

-0.06

(-0.52%)

Last updated on

Check the interactive Rapt Therapeutics Stock chart to analyse performance

Rapt Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$11.33
    Today's High:$11.40

    Day's Volatility :0.61%

  • 52 Weeks Low:$5.67
    52 Weeks High:$26.56

    52 Weeks Volatility :78.67%

Rapt Therapeutics Stock Returns

PeriodRapt Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
50.97%
3.6%
0.0%
6 Months
34.88%
-7.7%
0.0%
1 Year
-29.89%
-12.6%
0.0%
3 Years
-94.77%
9.5%
-4.7%

Rapt Therapeutics Inc Key Stats

Check Rapt Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$11.46
Open
$11.33
Today's High
$11.4
Today's Low
$11.33
Market Capitalization
$189.5M
Today's Volume
$17.8K
52 Week High
$26.56
52 Week Low
$5.6652
Revenue TTM
$0.0
EBITDA
$-112.0M
Earnings Per Share (EPS)
$-14.8
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-77.84%

Stock Returns calculator for Rapt Therapeutics Stock including INR - Dollar returns

The Rapt Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rapt Therapeutics investment value today

Current value as on today

₹75,829

Returns

₹24,171

(-24.17%)

Returns from Rapt Therapeutics Stock

₹29,455 (-29.46%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Rapt Therapeutics Stock

-95%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Rapt Therapeutics Stock from India on INDmoney has decreased by -95% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Rapt Therapeutics Inc

  • Name

    Holdings %

  • Medicxi Ventures Management (Jersey) Ltd

    16.90%

  • Orbimed Advisors, LLC

    9.93%

  • TCG Crossover Management, LLC

    9.90%

  • Foresite Capital Management VI LLC

    9.45%

  • RTW INVESTMENTS, LLC

    8.89%

  • Bvf Inc

    6.98%

Analyst Recommendation on Rapt Therapeutics Stock

Rating
Trend

Buy

    64%Buy

    35%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Rapt Therapeutics(by analysts ranked 0 to 5 stars)

Rapt Therapeutics Share Price Target

What analysts predicted

Upside of 95.91%

Target:

$22.33

Current:

$11.40

Rapt Therapeutics share price target is $22.33, a slight Upside of 95.91% compared to current price of $11.40 as per analysts' prediction.

Rapt Therapeutics Stock Insights

  • Price Movement

    In the last 3 months, RAPT stock has moved up by 60.0%
  • RAPT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 101.0%
  • RAPT vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 207.2%

Rapt Therapeutics Technicals Summary

Sell

Neutral

Buy

Rapt Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Rapt Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Rapt Therapeutics Inc logo
8.01%
34.88%
-29.89%
-94.77%
-95.14%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Rapt Therapeutics Inc

RAPT Therapeutics, Inc. operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company's lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Its lead oncology drug candidate is tivumecirnon (FLX475), an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Organization
Rapt Therapeutics
Employees
61
CEO
Dr. Brian Russell Wong M.D., Ph.D.
Industry
Health Technology

Key Management of Rapt Therapeutics Inc

NameTitle
Dr. Brian Russell Wong M.D., Ph.D.
CEO, President & Director
Mr. Rodney K. B. Young
CFO, Principal Accounting Officer & Secretary
Dr. William Ho M.D., Ph.D.
Chief Medical Officer
Steve Young Ph.D.
Vice President of Technology
Dr. Dirk G. Brockstedt Ph.D.
Chief Scientific Officer
Mr. Michael Listgarten
General Counsel
Ms. Gwen R. Carscadden
Chief Human Resources Officer
Dr. Paul Kassner Ph.D.
Senior Vice President of Biology
Ms. Jennifer Nicholson
Senior Vice President of Regulatory Affairs & Quality Assurance
Dr. Nipun Davar MBA, Ph.D.
Senior Vice President of Technical Operations

Important FAQs about investing in RAPT Stock from India :

What is Rapt Therapeutics share price today?

Rapt Therapeutics share price today is $11.40 as on at the close of the market. Rapt Therapeutics share today touched a day high of $11.40 and a low of $11.33.

What is the 52 week high and 52 week low for Rapt Therapeutics share?

Rapt Therapeutics share touched a 52 week high of $26.56 and a 52 week low of $5.67. Rapt Therapeutics stock price today i.e. is closed at $11.40, lower by 57.08% versus the 52 week high.

How to invest in Rapt Therapeutics Stock (RAPT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Rapt Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rapt Therapeutics Shares that will get you 0.1316 shares as per Rapt Therapeutics share price of $11.40 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Rapt Therapeutics Stock (RAPT) from India?

Indian investors can start investing in Rapt Therapeutics (RAPT) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Rapt Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Rapt Therapeutics share’s latest price of $11.40 as on August 30, 2025 at 1:29 am IST, you will get 0.8772 shares of Rapt Therapeutics. Learn more about fractional shares .

What are the returns that Rapt Therapeutics has given to Indian investors in the last 5 years?

Rapt Therapeutics stock has given -95.14% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?